On Wednesday, 10x Genomics Inc (NASDAQ:TXG) reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of $(0.30). The single-cell and spatial biology company reported quarterly sales of $165.02 million, down 10% year over year, beating the consensus of $159.39 million.

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

10x Genomics

10x Genomics (NASDAQ: TXG) is one of the fastest growing biotech companies, growing from $3M in revenue in 2015 to $240M in 2019

10X GENOMICS

10xgenomics.com

employees

Since 2012

COMPANY RANKING

10X GENOMICS

EVERGREEN INDEX #2370

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #10x Genomics

10x Genomics WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

10X GENOMICS

10xgenomics.com

employees

Since 2012

COMPANY RANKING

10X GENOMICS

EVERGREEN INDEX #2370

RELATED COMPANIESRANK

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #10x Genomics

10x Genomics WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!